Logotipo de Cepheid
Solicitar información
Ubicación/Idioma

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

{{initials}}

Main Menu
Ubicación/Idioma

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Solicitar información

Solicitar información

Xpert® MRSA/SA Blood Culture

MRSA/SA Blood Culture computer generated depiction.

MRSA and S. aureus detection from gram-positive blood culture samples in 62 minutes

La necesidad

an ill woman listens to a physician
  • Bloodstream infections cause an estimated 250.000 deaths annually in North America and Europe combined1
  • S. aureus and MRSA continue to be leading causes of bloodstream infections and are associated with increased length of stay and hospital costs2
  • Current culture-based lab testing methods for gram-positive blood culture bottles require an additional 24–72 hours for determination of S. aureus or MRSA
  • Early antimicrobial treatment for patient management2
1 Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.
Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA,
2 Parcel B, et al. Las pruebas moleculares rápidas de bacteriemia por Staphylococcus aureus mejoran el tratamiento clínico. J Med Microbiol. 2020 Mar;.

La solución

a male and a female researchers scanning cepheid test cartridges
The Xpert MRSA/SA Blood Culture test is a qualitative in vitro diagnostic test designed for rapid and simultaneous detection of S. aureus and methicillin-resistant S. aureus (MRSA) directly from gram-positive blood cultures.
The Xpert MRSA/SA Blood Culture test delivers:
  • Efficient laboratories with on-demand workflows that require minimal hands-on time
  • Optimized therapy with fast informed treatment decisions to help reduce empirical prescribing

El impacto

a smiling female doctor attends an elderly woman
  • Reduced result reporting turnaround time median of 24 hours, enabling earlier patient management review2
  • Enable earlier treatment with faster time to results3
  • Helps reduce length of stay3
2 Parcel B, et al. Las pruebas moleculares rápidas de bacteriemia por Staphylococcus aureus mejoran el tratamiento clínico. J Med Microbiol. 2020 Mar;.
3 Goff D, et al. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureu sblood culture test in
patients with S. aureus bacteremia. Clin Infect Dis. 2010

Conéctese para obtener más información

Solicitar información

Perspectivas

Get More Insights
Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web